Menlo Park, CA, United States of America

Deborah A Eppstein

This inventor holds 15 USPTO granted patents, primarily in Immunomodulatory Lipids. Top assignees: Syntex (u.s.a.) Inc., Other. Active years: 1985-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Deborah A Eppstein. Retrieved from https://idiyas.com/inventor/deborah-a-eppstein

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 15

% Patents Active = 100.0

Average Co-Inventor Count = 2.9

ph-index = 13

Forward Citations = 3,267(Granted Patents)

Location History:

Los Altos, CA (US) (1985 - 1989)
Menlo Park, CA (US) (1990 - 1997)
Palo Alto, CA (US) (1987 - 2002)

Company Filing History:

14 out of 932

Syntex (u.s.a.) Inc.

patents

1 out of 834,659

Other

patents

Years Active: 1985-2002

Loading Chart...

Areas of Expertise:

Immunomodulatory Activity

C-Reactive Protein

Dialkyloxy Lipids

Antiviral Composition

Controlled Release

Macromolecular Polypeptides

Muramyldipeptide

Liposomes

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6387395 - N-[1, (1-1) -dialkyloxy] - and N- [1, (1-1) -dialkenyloxy]- alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor (2002-05-14),

2. 5783179 - C-reactive protein fragment with immunomodulatory activity (1998-07-21),

3. 5622712 - N-[.omega., (.omega.-1)-dialkyloxy]- and N-[.omega., (1997-04-22),

4. 5550289 - N-(1,(1-1)-dialkyloxy)-and N-(1,(1-1)-dialkenyloxy (1996-08-27),

5. 5545412 - N-[1, (1-1)-dialkyloxy]-and N-[1, (1996-08-13),

6. 5366737 - N-[.omega.,(.omega.-1)-dialkyloxy]- and (1994-11-22),

7. 5208036 - N-(.omega., (.omega.-1)-dialkyloxy)- and N-(.omega., (1993-05-04),

8. 5049386 - N-.omega.,(.omega.-1)-dialkyloxy)- and (1991-09-17),

9. 4962091 - Controlled release of macromolecular polypeptides (1990-10-09),

10. 4946787 - N-(.omega.,(.omega.-1)-dialkyloxy)- and (1990-08-07),

11. 4897355 - N[.omega.,(.omega.-1)-dialkyloxy]- and (1990-01-30),

12. 4857316 - Synergistic antiviral composition (1989-08-15),

13. 4684625 - Method for enhancing the anti-infective activity of muramyldipeptide (1987-08-04),

14. 4606917 - Synergistic antiviral composition (1986-08-19),

15. 4522811 - Serial injection of muramyldipeptides and liposomes enhances the (1985-06-11),

Title: **Deborah A. Eppstein: Innovator in Immunology and Pharmaceutical Science**

Introduction

Deborah A. Eppstein is an accomplished inventor based in Menlo Park, California, recognized for her significant contributions to the fields of immunology and pharmaceutical science. With a remarkable portfolio of 15 patents, she is at the forefront of innovative solutions aimed at improving healthcare outcomes.

Latest Patents

Eppstein's latest patents demonstrate her commitment to advancing medical science. These include inventions related to N-[1, (1-1)-dialkyloxy] and N-[1, (1-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and their applications. Additionally, she has developed compounds featuring a dodecapeptide fragment A-(SEQ ID No: 1)-B, which corresponds to residues 174 to 185 of C-reactive protein (CRP). These compounds possess immunomodulatory activity and are integral to pharmaceutical compositions aimed at cancer treatment. Notably, Eppstein has explored the enhanced efficacy of liposomal formulations containing the CRP-peptide fragment, especially when used in conjunction with interleukin-2.

Career Highlights

Throughout her career, Deborah Eppstein has made a name for herself by working at prominent companies, including Syntex (U.S.A.) Inc. Her work has positioned her as a leader in the development of innovative treatments, particularly in immunology.

Collaborations

Eppstein has collaborated with notable colleagues such as Philip L. Felgner and Thomas R. Gadek. These collaborations have enabled her to expand her research horizons and contribute to significant advancements in the medical field.

Conclusion

Deborah A. Eppstein exemplifies the spirit of innovation in science and medicine. With her extensive patent portfolio and impactful contributions to immunology, she continues to inspire future generations of inventors and researchers dedicated to improving healthcare.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]